Clinical Pharmacogenetics Implementation Consortium Guideline for Cytochrome P450 ( CYP ) 2D6 Genotype and Atomoxetine Therapy-Reference-Cited by-同舟云学术

Clinical Pharmacogenetics Implementation Consortium Guideline for Cytochrome P450 ( CYP ) 2D6 Genotype and Atomoxetine Therapy

Published:2019-04-13 Issue:1 Volume:106 Page:94-102
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Brown Jacob T.¹,Bishop Jeffrey R.²,Sangkuhl Katrin³,Nurmi Erika L.⁴,Mueller Daniel J.⁵⁶,Dinh Jean C.⁷,Gaedigk Andrea⁷⁸,Klein Teri E.³,Caudle Kelly E.⁹,McCracken James T.⁴,Leon Jose¹⁰,Leeder J. Steven⁷⁸

Affiliation:

1. Department of Pharmacy Practice and Pharmaceutical SciencesUniversity of Minnesota College of Pharmacy Duluth Minnesota USA

2. Department of Experimental and Clinical PharmacologyCollege of PharmacyDepartment of PsychiatryMedical SchoolUniversity of Minnesota Minneapolis Minnesota USA

3. Department of Biomedical Data ScienceStanford University Stanford California USA

4. Division of Child and Adolescent PsychiatryDepartment of Psychiatry and Biobehavioral SciencesUniversity of California Los Angeles California USA

5. Campbell Family Mental Health Research InstituteCentre for Addiction and Mental Health Toronto Ontario Canada

6. Department of PsychiatryUniversity of Toronto Toronto Ontario Canada

7. Division of Clinical Pharmacology, Toxicology & Therapeutic InnovationDepartment of PediatricsChildren's Mercy Kansas City Kansas City Missouri USA

8. School of MedicineUniversity of Missouri‐Kansas City Kansas City Missouri USA

9. Department of Pharmaceutical SciencesSt. Jude Children's Research Hospital Memphis Tennessee USA

10. University of Kentucky Mental Health Research CenterEastern State Hospital Lexington Kentucky USA

Funder

National Institutes of Health

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cpt.1409

Reference38 articles.

1. PharmGKB.Gene Reference Materials for CYP2D6. Accessed September 16 2016.

2. Clinical Pharmacogenetics Implementation Consortium (CPIC).CPIC Guideline for Atomoxetine based on CYP2D6 genotype.

3. Clinical Pharmacogenetics Implementation Consortium Guidelines for Cytochrome P450 2D6 Genotype and Codeine Therapy: 2014 Update

4. The CYP2D6 Activity Score: Translating Genotype Information into a Qualitative Measure of Phenotype

5. Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for Codeine Therapy in the Context of Cytochrome P450 2D6 (CYP2D6) Genotype

Cited by 134 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Population Pharmacokinetic Analysis of Atomoxetine and its Metabolites in Children and Adolescents with Attention‐Deficit/Hyperactivity Disorder;Clinical Pharmacology & Therapeutics;2024-01-08

2. Pharmacogenetics and toxicology;Encyclopedia of Toxicology;2024

3. Clinical Genetics and Referrals;Genomics in the Clinic;2024

4. Attitudes of parents of children with ADHD towards genetic testing: Data from a Turkish sample;Journal of Genetic Counseling;2023-12-21

5. Therapeutisches Drug Monitoring: Ein Gebiet im Wandel;Trillium Diagnostik;2023-12-21